TWi Biotechnology, Inc. (TPEX:6610)

Taiwan · Delayed Price · Currency is TWD

19.40

+0.05 (0.26%)

Mar 24, 2026, 1:46 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Development and Transfer of New Drug Technologies				66.40M	1.25M	9.66M	25.84M	74.97M
Development and Transfer of New Drug Technologies Growth				5228.81%	-87.11%	-62.60%	-65.54%	-
Total				66.40M	1.25M	9.66M	25.84M	74.97M
Total Growth				5228.81%	-87.11%	-62.60%	-65.54%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Japan				25.12M	-	-	-	-
China				41.28M	-	-	-	-
United States				-	1.25M	9.66M	25.84M	74.97M
United States Growth				-	-87.11%	-62.60%	-65.54%	-
Total				66.40M	1.25M	9.66M	25.84M	74.97M
Total Growth				5228.81%	-87.11%	-62.60%	-65.54%	-

Source: S&P Global Market Intelligence.